Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Impact analysis of heart failure across European countries: an ESC-HFA position paper

Research output: Contribution to journalReviewpeer-review


  1. Healthcare resource use of patients with transthyretin amyloid cardiomyopathy

    Research output: Contribution to journalJournal articlepeer-review

  1. Three decades of heart transplantation: experience and long-term outcome

    Research output: Contribution to journalJournal articlepeer-review

  2. Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes

    Research output: Contribution to journalJournal articlepeer-review

  3. Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome

    Research output: Contribution to journalJournal articlepeer-review

  4. Alcohol Intake in Patients With Cardiomyopathy and Heart Failure: Consensus and Controversy

    Research output: Contribution to journalReviewpeer-review

  • Giuseppe M C Rosano
  • Petar Seferovic
  • Gianluigi Savarese
  • Ilaria Spoletini
  • Yuri Lopatin
  • Fin Gustafsson
  • Antoni Bayes-Genis
  • Tiny Jaarsma
  • Magdy Abdelhamid
  • Arantxa Gonzalez Miqueo
  • Massimo Piepoli
  • Carlo G Tocchetti
  • Arsen D Ristić
  • Ewa Jankowska
  • Brenda Moura
  • Loreena Hill
  • Gerasimos Filippatos
  • Marco Metra
  • Davor Milicic
  • Thomas Thum
  • Ovidiu Chioncel
  • Tuvia Ben Gal
  • Lars H Lund
  • Dimitrios Farmakis
  • Wilfried Mullens
  • Stamatis Adamopoulos
  • Michael Bohm
  • Anna Norhammar
  • Andreas Bollmann
  • Amitava Banerjee
  • Aldo P Maggioni
  • Adriaan Voors
  • Alain Cohen Solal
  • Andrew J S Coats
View graph of relations

Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.

Original languageEnglish
JournalESC Heart Failure
Publication statusE-pub ahead of print - 22 Jul 2022

Bibliographical note

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

ID: 79741882